Sequences

Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

3,061 publications in 1,851 families match these filters.

  1. WO 2013027823-A2013-02-28

    Method for measuring Glucagon-like peptide-1 and kit used therefor

    Mitsubishi Chemical Medience Corporation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  2. EP 2563808-A12013-03-06

    PEPTIDE CONJUGATES OF GLP-1 RECEPTOR AGONISTS AND GASTRIN AND THEIR USE

    ZEALAND PHARMA AS

    Query Match 100.0%Identity 100.0%Family of 6

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 6

    Grouped by the same title and applicant. No priority claim is on record.

  3. JP 2013509182-A2013-03-14

    Anti-GLP-1R Antibodies and Their Uses

    CENTOCOR ORTHO BIOTECH INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  4. EP 2568993-A12013-03-20

    GLUCAGON SUPERFAMILY PEPTIDES EXHIBITING G PROTEIN-COUPLED RECEPTOR ACTIVITY

    UNIV INDIANA RES & TECH CORP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  5. EP 2569000-A12013-03-20

    GLUCAGON SUPERFAMILY PEPTIDES EXHIBITING NUCLEAR HORMONE RECEPTOR ACTIVITY

    UNIV INDIANA RES & TECH CORP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  6. GLP-1 DERIVATIVES

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  7. EP 2573111-A12013-03-27

    GLP-1 compounds

    AMGEN INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  8. NOVEL GLUCAGON ANALOGUES

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  9. EP 2574624-A12013-04-03

    GLP-1 compounds

    AMGEN INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  10. DUAL FUNCTION PROTEINS FOR TREATING METABOLIC DISORDERS

    NOVARTIS AG

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  11. CYCLIC ANALOGS OF GLP-1 AND GLP-1 RELATED PEPTIDES AND USES THEREOF

    LANTHIOPEP B V

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  12. EP 2581389-A12013-04-17

    FUSION PROTEIN OF EXENDIN-4 AND ITS ANALOG, PREPARATION METHOD AND USE THEREOF

    BEIJING DONGFANG BIOTECH CO LTD

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  13. GLUCAGON BINDING NUCLEIC ACIDS

    NOXXON PHARMA AG

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  14. EP 2588127-A12013-05-08

    DIPEPTIDE LINKED MEDICINAL AGENTS

    UNIV INDIANA RES & TECH CORP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  15. JP 2013518115-A2013-05-20

    GLUCAGON ANTAGONIST-GIP AGONIST CONJUGATES AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS AND OBESITY

    Indiana University Research and technology Corporation

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 61/298812.

  16. PROTEINS WITH IMPROVED HALF-LIFE AND OTHER PROPERTIES

    ELEVEN BIOTHERAPEUTICS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  17. US 8450270-B22013-05-28

    Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers

    Indiana University Research and Technology Corporation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  18. GLUCAGON SUPERFAMILY PEPTIDES EXHIBITING NUCLEAR HORMONE RECEPTOR ACTIVITY

    INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  19. US 8476230-B22013-07-02

    Insulinotropic complex using an immunoglobulin fragment

    Hanmi Science Co., Ltd

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  20. US 8481490-B22013-07-09

    Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis

    Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  21. DIPEPTIDE LINKED MEDICINAL AGENTS

    INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  22. US 8501693-B22013-08-06

    Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen

    Amylin Pharmaceuticals, LLC and Astrazeneca Pharmaceuticals LP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  23. JP 2013531477-A2013-08-08

    SERUM ALBUMIN BINDING MOLECULES

    MICHAEL L GOSSELIN,DAVID FABRIZIO,JOANNA F SWAIN,TRACY MITCHELL, RAY CAMPHAUSEN,SHARON T CLOAD,ERIC FURFINE,PAUL E MORIN,RANJAN MUKHERJEE, SIMEON I TAYLOR

    Query Match 100.0%Identity 100.0%Family of 8

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 8

    Grouped by a shared priority claim, US 13/098851.

  24. US 8507428-B22013-08-13

    Glucagon analogs exhibiting GIP receptor activity

    Indiana University Research and Technology Corporation

    Query Match 100.0%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  25. US 8507429-B22013-08-13

    Sugar chain added GLP-1 peptide

    Glytech, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  26. JP 2013532172-A2013-08-15

    STABILIZED INSULINOTROPIC PEPTIDES AND METHODS OF USE

    DANA-FARBER CANCER INSTITUTE INC

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  27. US 8518876-B22013-08-27

    Composition for long-acting peptide analogs

    Pharmaln Corporation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  28. JP 2013533849-A2013-08-29

    Glucagon Superfamily Peptides Exhibiting G Protein-Coupled Receptor Activity

    DiMarchi et al

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  29. JP 2013534906-A2013-09-09

    Glucagon Superfamily Peptides Exhibiting Nuclear Hormone Receptor Agonist Activity

    DiMarchi et al

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  30. AMIDE BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS

    INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  31. US 8541368-B22013-09-24

    Glucagon analogues

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  32. COMPOSITIONS OF GLP-1 PEPTIDES AND PREPARATION THEREOF

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%Family of 11

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 11

    Grouped by the same title and applicant. No priority claim is on record.

  33. US 8546326-B22013-10-01

    Glp-1 analogue formulations

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  34. US 8551947-B22013-10-08

    Treatment of hibernating myocardium with an exendin peptide

    Amylin Pharmaceuticals, LLC and Astrazeneca Pharmaceuticals LP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  35. MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

    MODERNA THERAPEUTICS

    Query Match 100.0%Identity 100.0%Family of 8

    Best alignment and family

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

    Family of 8

    Grouped by a shared priority claim, US 61/618911.

  36. US 8557769-B22013-10-15

    Co-administration of FGF-21 and GLP-1 to treat diabetes and lower blood glucose

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  37. JP 2013540102-A2013-10-31

    Amide Based Glucagon Superfamily Peptide Prodrugs

    DiMarchi et al

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  38. US 8586006-B22013-11-19

    Organ-specific proteins and methods of their use

    Institute for Systems Biology and Integrated Diagnostics, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  39. US 8598314-B22013-12-03

    Peptide-peptidase-inhibitor conjugates and methods of making and using same

    Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  40. US 8603761-B22013-12-10

    GLP-1 receptor agonist bioassay

    Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  41. JP 2013545724-A2013-12-26

    Engineered Polypeptides Having Enhanced Duration of Action

    Amylin Pharmaceuticals Inc,Mary Erickson,David C Litzinger, Soumitra S Ghosh,Zijian Guo

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  42. TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  43. ANALOGS OF GLUCAGON EXHIBITING GIP RECEPTOR ACTIVITY

    UNIV INDIANA RES & TECH CORP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  44. INCRETIN RECEPTOR LIGAND POLYPEPTIDE FC-REGION FUSION POLYPEPTIDES AND CONJUGATES WITH ALTERED FC-EFFECTOR FUNCTION

    UNIV INDIANA RES & TECH CORP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  45. US 8617531-B22013-12-31

    Methods of making proteins and peptides containing a single free cysteine

    Bolder Biotechnology, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  46. EP 2681327-A22014-01-08

    VECTORS CONDITIONALLY EXPRESSING PROTEIN

    INTREXON CORP

    Query Match 100.0%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 5

    Grouped by a shared priority claim, US 61/449536.

  47. USE OF LONG-ACTING GLP-1 PEPTIDES

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  48. EP 2685257-A12014-01-15

    ANALYSIS METHOD

    SANWA KAGAKU KENKYUSHO CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  49. US 8633277-B22014-01-21

    Methods for forming polymer-drug conjugates

    Nektar Therapeutics

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  50. JP 2014501762-A2014-01-23

    METHODS FOR TREATING METABOLIC DISORDERS AND OBESITY WITH GIP AND GLP-1 RECEPTOR-ACTIVE GLUCAGON-BASED PEPTIDES

    Marcadia Biotech Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.